Literature DB >> 19869059

IMMUNOLOGICAL RELATIONSHIPS OF CELL CONSTITUENTS OF PNEUMOCOCCUS : SECOND PAPER.

O T Avery1, M Heidelberger.   

Abstract

In this paper the general immunological significance of the intact pneumococcus cell and of its protein and carbohydrate components is discussed.

Entities:  

Year:  1925        PMID： 19869059      PMCID： PMC2131014          DOI： 10.1084/jem.42.3.367

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


  9 in total

1.  The Agglutination Affinities of related Bacteria Parasitic in different Hosts.

Authors:  T Smith; A L Reagh
Journal:  J Med Res       Date:  1903-05

2.  THE NEUTRALIZATION OF ANTIPNEUMOCOCCUS IMMUNE BODIES BY INFECTED EXUDATES AND SERA.

Authors:  R Cole
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

3.  VARIATIONS IN SPECIFICITY AND VIRULENCE OF PNEUMOCOCCI DURING GROWTH IN VITRO.

Authors:  H A Reimann
Journal:  J Exp Med       Date:  1925-04-30       Impact factor: 14.307

4.  VARIATIONS IN THE PNEUMOCOCCUS INDUCED BY GROWTH IN IMMUNE SERUM.

Authors:  L M Stryker
Journal:  J Exp Med       Date:  1916-07-01       Impact factor: 14.307

5.  FURTHER STUDIES ON BACTERIAL HYPERSUSCEPTIBILITY. II.

Authors:  H Zinsser; J T Parker
Journal:  J Exp Med       Date:  1923-01-31       Impact factor: 14.307

6.  ON THE NATURE OF BACTERIAL ALLERGIES.

Authors:  H Zinsser; J H Mueller
Journal:  J Exp Med       Date:  1925-01-01       Impact factor: 14.307

7.  THE ELABORATION OF SPECIFIC SOLUBLE SUBSTANCE BY PNEUMOCOCCUS DURING GROWTH.

Authors:  A R Dochez; O T Avery
Journal:  J Exp Med       Date:  1917-10-01       Impact factor: 14.307

8.  THE CHEMICAL NATURE OF RESIDUE ANTIGEN PREPARED FROM YEAST.

Authors:  J H Mueller; J Tomcsik
Journal:  J Exp Med       Date:  1924-08-31       Impact factor: 14.307

9.  THE COMPOSITE NATURE OF A PURE CULTURE OF A VIRULENT PNEUMOCOCCUS.

Authors:  H L Amoss
Journal:  J Exp Med       Date:  1925-04-30       Impact factor: 14.307
  9 in total
  38 in total

1.  On the Significance of Bacterial Allergy in Infectious Diseases.

Authors:  H Zinsser
Journal:  Bull N Y Acad Med       Date:  1928-03

Review 2.  Antigenic Variation and Immune Escape in the MTBC.

Authors:  Joel D Ernst
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

3.  STUDIES ON IMMUNITY TO PNEUMOCOCCUS MUCOSUS (TYPE III) : II. THE INFECTIVITY OF TYPE III PNEUMOCOCCUS FOR RABBITS.

Authors:  W S Tillett
Journal:  J Exp Med       Date:  1927-05-31       Impact factor: 14.307

4.  THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS.

Authors:  R C Lancefield
Journal:  J Exp Med       Date:  1928-01-01       Impact factor: 14.307

5.  IN VITRO TRANSFORMATION OF PNEUMOCOCCAL TYPES : I. A TECHNIQUE FOR INDUCING TRANSFORMATION OF PNEUMOCOCCAL TYPES IN VITRO.

Authors:  M H Dawson; R H Sia
Journal:  J Exp Med       Date:  1931-10-31       Impact factor: 14.307

6.  THE IMMUNOLOGICAL SPECIFICITY OF STAPHYLOCOCCI : III. INTERRELATIONSHIPS OF CELL CONSTITUENTS.

Authors:  L A Julianelle; C W Wieghard
Journal:  J Exp Med       Date:  1935-06-30       Impact factor: 14.307

7.  IMMUNOLOGICAL PROPERTIES OF A TYPICAL (S-PRODUCING) AND A DEGRADED (NON-S-PRODUCING) STRAIN OF TYPE II PNEUMOCOCCUS WITH SPECIAL REFERENCE TO PROTECTIVE ANTIBODIES.

Authors:  E L Gaspari; W L Fleming; J M Neill
Journal:  J Exp Med       Date:  1927-06-30       Impact factor: 14.307

8.  STUDIES ON THE OXIDATION AND REDUCTION OF IMMUNOLOGICAL SUBSTANCES : X. IMMUNOLOGICAL DISTINCTIONS BETWEEN THE HEMOTOXIN AND THE "PROTEIN FRACTION" OF THE PNEUMOCOCCUS CELL.

Authors:  J M Neill; W L Fleming; E L Gaspari
Journal:  J Exp Med       Date:  1927-10-31       Impact factor: 14.307

9.  FACTORS INVOLVED IN THE PRODUCTION OF IMMUNITY WITH PNEUMOCOCCUS VACCINE : II. INDUCTION OF ACTIVE IMMUNITY DURING THE COURSE OF LOBAR PNEUMONIA.

Authors:  A L Barach
Journal:  J Exp Med       Date:  1931-03-31       Impact factor: 14.307

10.  SPECIFIC CUTANEOUS REACTIONS AND CIRCULATING ANTIBODIES IN THE COURSE OF LOBAR PNEUMONIA : II. CASES TREATED WITH ANTIPNEUMOCOCCIC SERA.

Authors:  M Finland; W D Sutliff
Journal:  J Exp Med       Date:  1931-10-31       Impact factor: 14.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.